IDEAS home Printed from https://ideas.repec.org/a/adp/jctoij/v7y2017i3p34-38.html
   My bibliography  Save this article

An Outcome of Localized HER2 Positive Breast Cancer Treated with Adjuvant Trastuzumab in Clinical Practice: Retrospective Observational Study

Author

Listed:
  • Musaab Raji Albayati

    (Department of Medical Oncology, Al-habobi Hospital, Iraq)

  • Haider Saadoon Alhilfi
  • Khalid Obiad Almohammadawi

    (Department of Medicine, University of Misan, Iraq)

  • Saad Muhsin Althaalibi

    (Department of Internal Medicine, Al-Sadder Teaching Hospital, Iraq)

Abstract

HER2 positive breast cancer is well known to be associated with poor prognosis. However, the prognosis of these patients has markedly improved since the introduction of trastuzumab for the treatment of HER2 positive breast cancer in the adjuvant and metastatic setting. The aim of this study was to determine the rate and pattern of recurrences in patients with HER2 positive breast cancer treated with adjuvant trastuzumab.

Suggested Citation

  • Musaab Raji Albayati & Haider Saadoon Alhilfi & Khalid Obiad Almohammadawi & Saad Muhsin Althaalibi, 2017. "An Outcome of Localized HER2 Positive Breast Cancer Treated with Adjuvant Trastuzumab in Clinical Practice: Retrospective Observational Study," Cancer Therapy & Oncology International Journal, Juniper Publishers Inc., vol. 7(3), pages 34-38, October.
    • Handle: RePEc:adp:jctoij:v:7:y:2017:i:3:p:34-38
    DOI: 10.19080/CTOIJ.2017.07.555712
    as

    Download full text from publisher

    File URL: https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555712.pdf
    Download Restriction: no
    File URL: https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555712.php
    Download Restriction: no
    File URL: https://libkey.io/10.19080/CTOIJ.2017.07.555712?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adp:jctoij:v:7:y:2017:i:3:p:34-38. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Robert Thomas (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.